Compounds > triazoles
Page last updated: 2024-08-24

triazoles and Acidosis, Renal Tubular

triazoles has been researched along with Acidosis, Renal Tubular in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bianchetti, MG; Brazzola, P; Dell'Orto, VG1
Chuang, GT; Lu, MY; Tsai, IJ; Tsau, YK1

Other Studies

2 other study(ies) available for triazoles and Acidosis, Renal Tubular

ArticleYear
Hyperchloraemic metabolic acidosis induced by the iron chelator deferasirox: a case report and review of the literature.
    Journal of clinical pharmacy and therapeutics, 2013, Volume: 38, Issue:6

    Topics: Acidosis; Acidosis, Renal Tubular; Adolescent; Benzoates; beta-Thalassemia; Chlorine; Deferasirox; Female; Humans; Iron Chelating Agents; Triazoles

2013
Transfusion-dependent thalassaemic patients with renal Fanconi syndrome due to deferasirox use.
    Nephrology (Carlton, Vic.), 2015, Volume: 20, Issue:12

    Topics: Acidosis, Renal Tubular; Adolescent; Benzoates; Blood Transfusion; Child; Child, Preschool; Deferasirox; Fanconi Syndrome; Female; Hospitals, University; Humans; Hypophosphatemia; Incidence; Iron Chelating Agents; Male; Retrospective Studies; Risk Factors; Taiwan; Thalassemia; Triazoles; Young Adult

2015